![Andrew Slee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Slee
Corporate Officer/Principal at
PROTAGENIC THERAPEUTICS, INC.
Net worth: - $ as of 30/07/2026
Profile
Andrew Slee is the founder of Vivisource Laboratories, Inc., founded in 2003.
Dr. Slee is Chief Development Officer at Protagenic Therapeutics, Inc. since 2025, with the role starting in 2016 and continuing currently.
Former jobs include Senior Director-Preclinical Pharmacology at Safety Pharmacology Society, Principal at DuPont Pharmaceuticals Co., Principal at DuPont Merck Pharmaceutical Co., Vice President-Pharmacology at Enanta Pharmaceuticals, Inc., and Vice President-Pharmacology & Development at SelectX Pharmaceuticals, Inc. from 2000 to 2012.
Education includes undergraduate studies at Syracuse University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/11/2025 | 0 ( -.--% ) | - $ | 30/07/2026 |
Andrew Slee active positions
| Companies | Position | Start |
|---|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Corporate Officer/Principal | 14/05/2025 |
Former positions of Andrew Slee
| Companies | Position | End |
|---|---|---|
Vivisource Laboratories, Inc. | Founder | 30/09/2013 |
SelectX Pharmaceuticals, Inc.
 SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops aminoglycoside therapeutics | Corporate Officer/Principal | - |
| ENANTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Corporate Officer/Principal | - |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Corporate Officer/Principal | - |
Training of Andrew Slee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
17
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
SelectX Pharmaceuticals, Inc.
SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops aminoglycoside therapeutics | Health Technology |
Vivisource Laboratories, Inc. | |
Safety Pharmacology Society
 Safety Pharmacology Society Miscellaneous Commercial ServicesCommercial Services Safety Pharmacology Society is an international nonprofit organization that promotes knowledge, development, application, and training in safety pharmacology, a scientific discipline that integrates pharmacology, physiology, and toxicology. The private company is based in Reston, VA. The society aims to advance the discovery, development, and safe use of biologically active chemical entities by identifying, monitoring, and characterizing potentially undesirable pharmacodynamic activities in nonclinical studies. It supports human safety of drugs and biologicals through scientific research, education, and dissemination of information via meetings and other interactions. The society has established a certification process to evaluate and document competency in safety pharmacology, addressing industry and regulatory needs for expertise and quality standards. | Commercial Services |
Protagenic Therapeutics, Inc.
 Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders | Health Technology |
- Stock Market
- Insiders
- Andrew Slee
